Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ceri A Fielding

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|July 2, 2011
Interleukin-19: a new target to aim for?Ceri A Fielding
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 19, 2008
Piece by piece: solving the puzzle of peritoneal fibrosisCeri A Fielding, Nicholas Topley
The Journal of Clinical Investigation|March 1, 2022
Concerns over functional experiments, interpretation, and required controlsEddie Cy Wang, Ceri A Fielding, Richard J Stanton
FEBS Letters|July 15, 2004
Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expressionCeri A Fielding, Stefan Siebert, Martin Rowe, et al.
FEBS Letters|September 16, 2005
Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expressionStefan Siebert, Ceri A Fielding, Bryan D Williams, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 12, 2014
Interleukin-6 in renal disease and therapySimon A Jones, Donald J Fraser, Ceri A Fielding, et al.
Virus Evolution|September 24, 2024
Evolution of the <i>Cytomegalovirus</i> RL11 gene family in Old World monkeys and Great ApesUlad Litvin, Eddie C Y Wang, Richard J Stanton, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafineColin S Osborne, Ingrid Leitner, Bettina Hofbauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
ERK is integral to the IFN-γ-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophagesNa Li, James E McLaren, Daryn R Michael, et al.
The American Journal of Pathology|June 27, 2007
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivoBarbara Coles, Ceri A Fielding, Stefan Rose-John, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|July 2, 2011
Interleukin-19: a new target to aim for?Ceri A Fielding
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 19, 2008
Piece by piece: solving the puzzle of peritoneal fibrosisCeri A Fielding, Nicholas Topley
The Journal of Clinical Investigation|March 1, 2022
Concerns over functional experiments, interpretation, and required controlsEddie Cy Wang, Ceri A Fielding, Richard J Stanton
FEBS Letters|July 15, 2004
Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expressionCeri A Fielding, Stefan Siebert, Martin Rowe, et al.
FEBS Letters|September 16, 2005
Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expressionStefan Siebert, Ceri A Fielding, Bryan D Williams, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 12, 2014
Interleukin-6 in renal disease and therapySimon A Jones, Donald J Fraser, Ceri A Fielding, et al.
Virus Evolution|September 24, 2024
Evolution of the <i>Cytomegalovirus</i> RL11 gene family in Old World monkeys and Great ApesUlad Litvin, Eddie C Y Wang, Richard J Stanton, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafineColin S Osborne, Ingrid Leitner, Bettina Hofbauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
ERK is integral to the IFN-γ-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophagesNa Li, James E McLaren, Daryn R Michael, et al.
The American Journal of Pathology|June 27, 2007
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivoBarbara Coles, Ceri A Fielding, Stefan Rose-John, et al.
Pageof 5